We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$35.5B
AUM Growth
+$586M
Cap. Flow
-$946M
Cap. Flow %
-2.67%
Top 10 Hldgs %
25.54%
Holding
2,317
New
189
Increased
687
Reduced
1,108
Closed
152

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$418M
2
ED icon
Consolidated Edison
ED
+$212M
3
CCI icon
Crown Castle
CCI
+$103M
4
TGT icon
Target
TGT
+$93.8M
5
SAGE
Sage Therapeutics
SAGE
+$72M

Sector Composition

Rank Sector Weight
1 Consumer Staples 14.38%
2 Healthcare 14.1%
3 Communication Services 10.76%
4 Technology 10.06%
5 Utilities 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMI icon
826
Cummins
CMI
$72.6B
$2.62M 0.01%
14,857
-1,486
-9% -$254K
VVC
827
DELISTED
Vectren Corporation
VVC
$2.61M 0.01%
40,172
-4,071
-9% -$273K
FRME icon
828
First Merchants
FRME
$2.58B
$2.61M 0.01%
62,025
-1,383
-2% -$59.1K
LPT
829
DELISTED
Liberty Property Trust
LPT
$2.61M 0.01%
60,625
-12,472
-17% -$541K
KMG
830
DELISTED
KMG Chemicals Inc
KMG
$2.6M 0.01%
39,383
+7,013
+22% +$397K
CRL icon
831
Charles River Laboratories
CRL
$13.1B
$2.6M 0.01%
23,766
-4,236
-15% -$461K
FIX icon
832
Comfort Systems
FIX
$55.9B
$2.59M 0.01%
59,260
+408
+0.7% +$16.7K
R icon
833
Ryder
R
$9.13B
$2.57M 0.01%
30,520
-2,989
-9% -$244K
UTHR icon
834
United Therapeutics
UTHR
$21.4B
$2.57M 0.01%
17,366
-6,632
-28% -$843K
ESNT icon
835
Essent Group
ESNT
$6.1B
$2.56M 0.01%
58,996
+6,737
+13% +$294K
DCI icon
836
Donaldson
DCI
$10B
$2.56M 0.01%
52,300
-8,665
-14% -$413K
NBR icon
837
Nabors Industries
NBR
$1.3B
$2.56M 0.01%
7,493
+2,023
+37% +$644K
FAF icon
838
First American
FAF
$7.26B
$2.55M 0.01%
45,457
-9,105
-17% -$490K
NTGR icon
839
NETGEAR
NTGR
$618M
$2.54M 0.01%
43,177
-84,270
-66% -$4.32M
DCH
840
Dauch Corp
DCH
$1.43B
$2.53M 0.01%
148,709
+18,805
+14% +$333K
DNOW icon
841
DNOW Inc
DNOW
$2.82B
$2.53M 0.01%
229,617
-58,489
-20% -$668K
AUB icon
842
Atlantic Union Bankshares
AUB
$5.59B
$2.52M 0.01%
69,742
-1,213
-2% -$43.3K
CHFN
843
DELISTED
Charter Financial Corp
CHFN
$2.52M 0.01%
143,608
+38,904
+37% +$717K
KNL
844
DELISTED
Knoll, Inc.
KNL
$2.52M 0.01%
109,353
-6,284
-5% -$131K
OPTU
845
Optimum Communications Inc
OPTU
$385M
$2.52M 0.01%
+118,455
New +$2.62M
OLLI icon
846
Ollie's Bargain Outlet
OLLI
$4.35B
$2.52M 0.01%
47,220
+45,992
+3,745% +$2.17M
LCI
847
DELISTED
Lannett Company, Inc.
LCI
$2.51M 0.01%
27,059
+3,399
+14% +$331K
GNC
848
DELISTED
GNC Holdings, Inc.
GNC
$2.5M 0.01%
678,120
-82,743
-11% -$520K
ACM icon
849
Aecom
ACM
$8.08B
$2.5M 0.01%
67,229
-19,235
-22% -$700K
WAB icon
850
Wabtec
WAB
$46.7B
$2.5M 0.01%
30,673
-4,746
-13% -$363K

Similar funds

Federated Hermes's Q4 2017 Portfolio in Review

As of Q4 2017, Federated Hermes held 2,317 positions worth $35.5B, up 1.7% from $34.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Federated Hermes's Q4 2017 filing shows 189 new, 687 increased, 1,108 reduced and 152 closed positions. Its largest new stake was Azul: 1,190,200 shares worth $28.4M. The largest sale was AbbVie, an estimated $418M.

By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Communication Services.

  • Federated Hermes's largest Q4 2017 buy was Azul: 1,190,200 shares worth $28.4M.
  • Federated Hermes added most to British American Tobacco in Q4 2017, an estimated $104M increase.
  • Federated Hermes's biggest Q4 2017 reduction was AbbVie, cutting an estimated $418M.
  • Federated Hermes fully exited iShares Biotechnology ETF in Q4 2017, selling an estimated $36.1M.
  • Federated Hermes's ten largest holdings make up 26% of its $35.5B portfolio in Q4 2017.
  • Federated Hermes opened 189 new positions and closed 152 in Q4 2017.
  • Federated Hermes's portfolio value rose 1.7% quarter-over-quarter to $35.5B.

Based on Federated Hermes's 13F filing for Q4 2017, filed 14 Feb 2018.